OMICS A Journal of Integrative Biology · 2011 · 52 citations · 44 references
Life SciencesPharmacokineticsPharmacologyDrug MetabolismMass Spectrometric AnalysisMetabolomicsAmino Acid MetabolomicsClinical MetabolomicsMass Spectrometry-based MetabolomicsMetabolite IdentificationMetabolite ProfilingMetabolite QuantificationAmino AcidsDifferential Metabolite AnalysisEarly Antiretroviral TherapyLevel-based Metabolite IdentificationMetabolite PharmacokineticsMetabolome Data AnalysisMetabolomic SignaturesTyrosine Biosynthesis
The objective of the current study was to characterize the profile of oral metabolites in HIV-infected patients using metabolomics. Oral wash samples were collected from 12 HIV-infected and 12 healthy individuals (matched for age, sex, and ethnicity), processed, and analyzed by metabolomics. We detected 198 identifiable and 85 nonidentifiable metabolites; 27 identifiable metabolites were differentially present (12 increased, 15 decreased) in HIV-infected patients. Elevated metabolites included p-cresol sulfate, nucleotides (e.g., allantoin), and amino acids (e.g., phenylalanine, tryptophan), whereas decreased oral metabolites included fucose, fumarate, and N-acetylglucosamine. Pathway network analysis revealed the largest multinode network in healthy versus HIV-infected patients to involve carbohydrate biosynthesis and degradation. HIV-infected patients on antiretroviral therapy (ART) showed the largest number (12) of statistically significant metabolite correlation differences compared with healthy controls. Interestingly, the oral phenlyalanine:tyrosine ratio increased in ART-naive HIV-infected patients (mean ± SEM = 2.58 ± 0.87) compared with healthy individuals (1.33 ± 0.10, p = 0.062) or ART-experienced patients (1.78 ± 0.30, p = 0.441). This is the first study to reveal differential levels of oral metabolites in HIV-infected patients compared withj healthy volunteers, and that oral phenlyalanine:tyrosine ratio may be a useful marker for noninvasive monitoring of the immune status during HIV infection.
44
Cytoscape: A Software Environment for Integrated Models of Biomolecular Interaction Networks
Paul Shannon, Andrew Markiel, Owen Ozier et al. · Genome Research · 2003 · 54.3K citations · Full text
Integration of biological networks and gene expression data using Cytoscape
Melissa Cline, Michael Smoot, Ethan Cerami et al. · Nature Protocols · 2007 · 2.6K citations
Metabolomic profiles delineate potential role for sarcosine in prostate cancer progression
Arun Sreekumar, Laila Poisson, Thekkelnaycke M. Rajendiran et al. · Nature · 2009 · 2.2K citations · Full text
Medicine, Cancer Biology, Oncology +16
Anne M. Evans, Corey D. DeHaven, Tom Barrett et al. · Analytical Chemistry · 2009 · 1.4K citations